SQUIZZATO, ALESSANDRO
 Distribuzione geografica
Continente #
NA - Nord America 28.306
EU - Europa 13.939
AS - Asia 8.944
SA - Sud America 925
AF - Africa 157
Continente sconosciuto - Info sul continente non disponibili 33
OC - Oceania 17
Totale 52.321
Nazione #
US - Stati Uniti d'America 27.985
IT - Italia 6.032
SG - Singapore 2.769
UA - Ucraina 1.949
CN - Cina 1.940
TR - Turchia 1.416
RU - Federazione Russa 1.362
VN - Vietnam 1.196
SE - Svezia 996
DE - Germania 989
HK - Hong Kong 967
BR - Brasile 760
IE - Irlanda 579
FI - Finlandia 551
GB - Regno Unito 542
FR - Francia 494
IN - India 182
CA - Canada 149
BD - Bangladesh 145
MX - Messico 126
NL - Olanda 87
JP - Giappone 70
PL - Polonia 58
AR - Argentina 56
ES - Italia 52
AT - Austria 50
NG - Nigeria 48
IQ - Iraq 44
BE - Belgio 38
CZ - Repubblica Ceca 32
EU - Europa 31
ZA - Sudafrica 30
PK - Pakistan 28
LT - Lituania 25
CO - Colombia 21
MD - Moldavia 19
SA - Arabia Saudita 19
UZ - Uzbekistan 19
VE - Venezuela 19
CL - Cile 17
EC - Ecuador 16
PH - Filippine 16
PT - Portogallo 15
TN - Tunisia 15
AU - Australia 14
EG - Egitto 14
AE - Emirati Arabi Uniti 13
ID - Indonesia 13
MY - Malesia 13
RO - Romania 13
JO - Giordania 12
PY - Paraguay 12
KE - Kenya 10
MA - Marocco 10
NP - Nepal 10
BO - Bolivia 9
CH - Svizzera 9
JM - Giamaica 9
PE - Perù 9
TH - Thailandia 9
DZ - Algeria 8
HR - Croazia 8
IL - Israele 8
OM - Oman 7
RS - Serbia 7
CR - Costa Rica 6
KR - Corea 6
SN - Senegal 6
UY - Uruguay 6
AL - Albania 5
ET - Etiopia 5
MK - Macedonia 5
BG - Bulgaria 4
DK - Danimarca 4
DO - Repubblica Dominicana 4
GR - Grecia 4
GT - Guatemala 4
HN - Honduras 4
HU - Ungheria 4
LB - Libano 4
TT - Trinidad e Tobago 4
TW - Taiwan 4
AI - Anguilla 3
AM - Armenia 3
AZ - Azerbaigian 3
BB - Barbados 3
GE - Georgia 3
KZ - Kazakistan 3
NI - Nicaragua 3
NZ - Nuova Zelanda 3
QA - Qatar 3
CG - Congo 2
IR - Iran 2
KG - Kirghizistan 2
KH - Cambogia 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
MN - Mongolia 2
NO - Norvegia 2
PS - Palestinian Territory 2
Totale 52.295
Città #
Milan 4.100
Fairfield 3.305
Woodbridge 2.391
Ashburn 2.192
San Jose 1.866
Houston 1.775
Jacksonville 1.533
Dallas 1.521
Singapore 1.492
Chandler 1.396
Seattle 1.341
Ann Arbor 1.253
Wilmington 1.208
Cambridge 1.116
Moscow 1.012
Hong Kong 950
Izmir 660
Princeton 596
Dublin 576
Dearborn 515
Nyköping 461
The Dalles 447
Beijing 446
Boardman 377
Rome 313
Dong Ket 301
Lauterbourg 298
Chicago 281
Council Bluffs 219
New York 206
Ho Chi Minh City 203
Munich 201
Los Angeles 190
San Diego 172
Como 171
San Mateo 154
Hanoi 149
London 141
Santa Clara 135
Helsinki 114
Ogden 110
Orem 95
Mexico City 92
São Paulo 83
Guangzhou 81
Hefei 71
Kocaeli 67
Tokyo 65
Chennai 61
Frankfurt am Main 61
Washington 61
Düsseldorf 58
Montreal 57
Kunming 52
Redmond 50
Brooklyn 47
Nanjing 46
Shanghai 46
Abuja 45
Warsaw 45
Verona 44
Nuremberg 43
Phoenix 43
Denver 41
Boston 37
Haiphong 36
Amsterdam 35
Norwalk 35
Tianjin 35
Turku 35
Buffalo 34
Stockholm 33
Brussels 32
Toronto 32
Rio de Janeiro 30
Nanchang 29
Shenzhen 29
Atlanta 28
Jinan 28
San Francisco 28
Brno 27
Hangzhou 27
Manchester 27
Zhengzhou 27
Des Moines 26
Poplar 25
Berlin 24
Mumbai 24
Columbus 23
Johannesburg 23
Redwood City 23
Varese 22
Vienna 21
Belo Horizonte 20
Da Nang 20
Philadelphia 19
Schiffdorf 19
Falls Church 18
Prescot 18
Salt Lake City 18
Totale 38.208
Nome #
10 years of stagnant clinical research in the Italian academic context 2.130
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both 400
Impact of neutrophils to lymphocytes ratio on major clinical outcomes in patients with acute coronary syndromes: A systematic review and meta-analysis of the literature 379
Brain and kidney, victims of atrial microembolism in elderly hospitalized patients? Data from the REPOSI study 337
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 291
Multimorbidity and polypharmacy in the elderly: lessons from REPOSI. 282
Abdominal obesity and the risk of recurrent deep vein thrombosis 272
A case report and literature review of portal vein thrombosis associated with Cytomegalovirus infection in immunocompetent patients 268
Relationship between regulatory T cells subsets and lipid profile in dyslipidemic patients: A longitudinal study during atorvastatin treatment 268
Oral anticoagulant therapy in patients with mechanical heart valve and intracranial haemorrhage. A systematic review 262
Risk of recurrence of unusual site venous thromboembolism 257
Acquired von Willebrand syndrome in patients with overt hypothyroidism: a prospective cohort study 255
Optimal treatment duration of venous thrombosis 251
Heart failure and chronic kidney disease in a registry of internal medicine wards 251
Pulmonary Embolism Severity Index Accurately Predicts Long-Term Mortality Rate In Patients Hospitalized For Acute Pulmonary Embolism 250
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 248
Anticoagulant therapy for venous thromboembolism during pregnancy: a systematic review and a meta-analysis of the literature 247
Vitamin D Deficiency has a Negative Impact on Cetuximab-Mediated Cellular Cytotoxicity against Human Colon Carcinoma Cells 244
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients 243
Gender-differences in disease distribution and outcome in hospitalized elderly: data from the REPOSI study. 241
PCSK9 inhibitors for treating dyslipidemia in patients at different cardiovascular risk: a systematic review and a meta-analysis 239
Antiplatelet drugs for polycythaemia vera and essential thrombocythaemia 238
Association between ABCG2 and ABCB1 genes and warfarin stability: a case-control study 235
Prevalence and Risk Factors Associated with Use of QT-Prolonging Drugs in Hospitalized Older People 235
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 235
Unsuspected pulmonary embolism in cancer patients: a narrative review with pooled data 232
Subclinical hypothyroidism and deep venous thrombosis. A pilot cross-sectional study 230
A new era for venous thromboembolism prevention in medical inpatients 230
Incidence rates and case fatality rates of portal vein thrombosis and Budd-Chiari Syndrome 230
Diagnosis and management of venous thromboembolism: Results of a survey on current clinical practice 229
Diagnosis of overt and non-overt disseminated intravascular coagulation: A survey among experts and a call for action from the ISTH 229
A systematic review on the effect of aspirin in the prevention of post-operative arterial thrombosis in patients undergoing total hip and total knee arthroplasty 229
Diagnostic accuracy of lung ultrasound for pulmonary embolism: a systematic review and meta-analysis. 226
Prevalence and Clinical History of Incidental, Asymptomatic Pulmonary Embolism: A Meta-Analysis 225
Incidence of chronic pulmonary hypertension in patients with previous pulmonary embolism 223
Differential diagnosis of pulmonary embolism in outpatients with non-specific cardiopulmonary symptoms. 222
Effect of thromboprophylaxis with anticoagulant drugs on the incidence of arterial thrombotic events in medical inpatients: a systematic review 219
Applying EBM in clinical practice 218
Patient selection for thromboprophylaxis in medical inpatients 218
Cangrelor for the treatment of arterial thrombosis: pharmacokinetics/pharmacodynamics and clinical data 218
Antiplatelet drugs for polycythaemia vera and essential thrombocythaemia 217
Prevention of venous thromboembolism and persistent vegetative state: a medical and an ethical issue 216
Presence of residual thromboemboli at least six months after a first episode of symptomatic pulmonary embolism: do perfusion scintigraphy and angio-computed tomography agree? 216
Imatinib discontinuation in chronic myeloid leukaemia patients with undetectable BCR-ABL transcript level: A systematic review and a meta-analysis 216
Post-operative arterial thrombosis with non-vitamin K antagonist oral anticoagulants after total hip or knee arthroplasty 214
Abdominal obesity and the risk of recurrent deep vein thrombosis. 213
Statins, fibrates, and venous thromboembolism: a meta-analysis. 213
Non-vitamin K oral anticoagulants in patients with pulmonary embolism: a systematic review and meta-analysis of the literature 212
Prognostic stratification of chronic heart failure in elderly population: are cardiopulmonary tests and BNP really valuable? 210
ESC position paper on cardiovascular toxicity of cancer treatments: challenges and expectations—comment 209
Atypical case of Acute Coronary Syndrome due to Coronary-Pulmonary Steal Syndrome secondary to Pulmonary Embolism. 208
Pulmonary embolism prognostic factors and length of hospital stay: A cohort study 208
Predictors of residual venous obstruction after deep vein thrombosis of the lower limbs: a prospective cohort study 206
Incidence of cancer after a first episode of idiopathic venous thromboembolism treated with 3 months or 1 year of oral anticoagulation 205
Time trends and case fatality rate of in-hospital treated pulmonary embolism during 11 years of observation in Northwestern Italy 204
Joint use of cardio-embolic and bleeding risk scores in elderly patients with atrial fibrillation 203
Thrombosis Associated with Viral Hepatitis 202
Treating patients with cancer and acute venous thromboembolism 202
Alterations in coagulation and fibrinolysis after levothyroxine exposure in healthy volunteers: a controlled randomized crossover study. 201
Balloon Pulmonary Angioplasty in Patients With Chronic Thromboembolic Pulmonary Hypertension - A Systematic Review and Meta-Analysis - 200
Statins and secondary prevention of ischemic and hemorrhagic stroke 198
Anticoagulant therapy for venous thromboembolism during pregnancy: a systematic review and a meta-analysis of the literature: a reply to a rebuttal 198
Diagnostic accuracy of magnetic resonance imaging in patients with suspected pulmonary embolism: A bivariate meta-analysis 198
sRAGE and early signs of cardiac target organ damage in mild hypertensives 196
Imaging for the diagnosis of pulmonary embolism in very obese patients; a survey among internists and radiologists in Italy and the Netherlands 195
Gender Difference in Efficacy and Safety of Nonvitamin K Antagonist Oral Anticoagulants in Patients with Nonvalvular Atrial Fibrillation or Venous Thromboembolism: A Systematic Review and a Meta-Analysis of the Literature 195
Statins for acute ischemic stroke 195
In vitro effects of Apixaban on 5 different cancer cell lines 195
Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular disease. 194
Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register 193
Prophylaxis of venous thromboembolism in elderly patients with multimorbidity 193
Evaluation of the prevalence of severe hyperhomocysteinemia in adult patients with thrombosis who underwent screening for thrombophilia 193
Effects of mineralocorticoid receptor antagonists on the risk of thrombosis, bleeding and mortality: A systematic review and meta-analysis of randomized controlled trials 193
Implementation of the Frailty Index in hospitalized older patients: Results from the REPOSI register 193
Factors associated with anticoagulation prescription in elderly patients with atrial fibrillation 193
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 192
An unusual case of cerebral vein thrombosis in a patient with giant cell arteritis 190
Hypothyroidism and acquired von Willebrand's syndrome: a systematic review 190
The stigma of low opioid prescription in the hospitalized multimorbid elderly in Italy 189
Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular events 189
Appropriateness of oral anticoagulant therapy prescription and its associated factors in hospitalized older people with atrial fibrillation 189
The role of thrombolytic therapy in pulmonary embolism 188
Epidemiology and secondary prevention of ischemic stroke in patients on antiplatelet drug: a retrospective cohort study 188
JAK2V617F mutation for the early diagnosis of Ph- myeloproliferative neoplasms in patients with venous thromboembolism: a meta-analysis. 188
Antiplatelet drugs for polycythaemia vera and essential thrombocythaemia: a Cochrane meta-analysis. 186
Atypical case of acute coronary syndrome due to coronary-pulmonary steal syndrome secondary to pulmonary embolism. 185
Certoparin for the treatment and prevention of thrombosis: pharmacological profile and results from clinical studies 184
How I treat splanchnic vein thrombosis 184
The effect of thyroid autoantibodies on warfarin stability 184
Antithrombotic and fibrinolytic drugs for retinal vein occlusion: a systematic review and a call for action. 184
Drug–drug interactions involving CYP3A4 and p-glycoprotein in hospitalized elderly patients 183
Antithrombotic therapy and cancer. 181
Thyroid dysfunction and effects on coagulation and fibrinolysis - a systematic review 181
The initial phase of oral anticoagulation with warfarin in outpatients with deep venous thrombosis. 181
Oral Anticoagulation Therapy in Heart Failure Patients in Sinus Rhythm: A Systematic Review and Meta-Analysis 181
Aspirin plus clopidogrel vs aspirin alone for preventing cardiovascular events among patients at high risk for cardiovascular events 181
Disability, and not diabetes, is a strong predictor of mortality in oldest old patients hospitalized with pneumonia 180
Clinical review: Thyroid dysfunction and effects on coagulation and fibrinolysis: a systematic review 179
Subclinical hypothyroidism and deep venous thrombosis. A pilot cross-sectional study 179
Oral anticoagulant therapy in patients with mechanical heart valve and intracranial haemorrhage: A systematic review 179
Totale 23.648
Categoria #
all - tutte 205.619
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 205.619


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.250 385 490 178 106 171 225 146 167 165 537 285 395
2022/20233.882 413 208 310 405 280 835 17 492 571 125 111 115
2023/20247.591 1.064 1.033 1.056 1.222 1.255 595 428 435 171 210 43 79
2024/20254.596 46 46 829 111 136 320 305 373 464 384 388 1.194
2025/202612.313 788 902 1.235 1.409 980 727 2.451 681 1.442 780 553 365
2026/2027253 253 0 0 0 0 0 0 0 0 0 0 0
Totale 52.710